03-08-2023 |
AH |
|
DLB |
Dolby Laboratories |
8,490 |
0.32 |
0.29 |
0.42 |
Dolby Laboratories Non-GAAP EPS of $0.55 in-line, revenue of $298.4M misses by $3.25M [8/3/2023 5:15 PM] |
79.32 |
-8.52 (-9.70%) |
87.80 |
-0.04 (-0.05%) |
61.55 - 91.01 |
968,463 |
290,000 |
24,050 |
|
|
04-05-2023 |
AH |
4:15 PM ET (May 4) |
DLB |
Dolby Laboratories |
7,900 |
1.00 |
0.70 |
0.70 |
Dolby Laboratories Non-GAAP EPS of $1.26 beats by $0.29, revenue of $375.9M beats by $26.05M [5/4/2023 4:34 PM] |
84.61 |
2.79 (3.41%) |
82.75 |
0.93 (1.14%) |
61.55 - 88.06 |
285,957 |
300,000 |
2,210 |
|
|
02-02-2023 |
AH |
4:15 PM ET (Feb 2) |
DLB |
Dolby Laboratories |
7,460 |
0.83 |
0.52 |
0.79 |
Dolby FQ1 results beat estimates, co guides FQ2 2023 revenue above consensus [2/2/2023 4:38 PM] |
86.80 |
4.13 (5.00%) |
82.67 |
0.0 (0.00%) |
61.55 - 88.06 |
573,060 |
440,000 |
5,373 |
|
|
17-11-2022 |
AH |
4:15 PM ET (Nov 17) |
DLB |
Dolby Laboratories |
6,890 |
0.33 |
0.47 |
0.43 |
Dolby Laboratories Non-GAAP EPS of $0.54 misses by $0.17, revenue of $278.2M misses by $27.03M [11/17/2022 4:27 PM] |
68.96 |
-0.79 (-1.13%) |
69.75 |
0.0 (0.00%) |
61.55 - 96.85 |
871,403 |
380,000 |
6,106 |
|
|
09-08-2022 |
AH |
4:15 PM ET (Aug 9) |
DLB |
Dolby Laboratories |
7,750 |
0.42 |
0.37 |
0.52 |
Dolby Laboratories Non-GAAP EPS of $0.68 beats by $0.09, revenue of $289.59M misses by $4.44M [8/9/2022 4:27 PM] |
79.15 |
3.65 (4.83%) |
75.50 |
0.0 (0.00%) |
69.18 - 104.25 |
739,709 |
400,000 |
2,828 |
|
|
05-05-2022 |
AH |
4:15 PM ET (May 5) |
DLB |
Dolby Laboratories |
7,990 |
0.70 |
0.60 |
0.73 |
Dolby Laboratories Non-GAAP EPS of $0.92 beats by $0.10, revenue of $334.4M beats by $1.89M [5/5/2022 4:53 PM] |
71.59 |
-3.84 (-5.09%) |
73.89 |
-1.54 (-2.04%) |
69.18 - 104.25 |
1,375,011 |
670,000 |
106 |
|
|
03-02-2022 |
AH |
4:15 PM ET (Feb 3) |
DLB |
Dolby Laboratories |
8,880 |
0.79 |
0.84 |
1.28 |
Dolby Laboratories Non-GAAP EPS of $1.01 misses by $0.05, revenue of $351.6M misses by $10.62M [2/3/2022 4:31 PM] |
75.74 |
-9.55 (-11.20%) |
85.29 |
0.0 (0.00%) |
75.36 - 104.74 |
1,276,074 |
390,000 |
2,950 |
|
|
16-11-2021 |
AH |
4:15 PM ET (Nov 16) |
DLB |
Dolby Laboratories |
9,120 |
0.43 |
0.38 |
0.28 |
Dolby Laboratories EPS beats by $0.02, misses on revenue [11/16/2021 4:24 PM] |
87.80 |
-1.15 (-1.29%) |
82.61 |
-6.34 (-7.13%) |
85.24 - 104.74 |
1,019,263 |
330,000 |
10,280 |
|
|
29-07-2021 |
AH |
4:15 PM ET (Jul 29) |
DLB |
Dolby Laboratories |
9,650 |
0.52 |
0.30 |
0.70 |
Dolby Laboratories EPS beats by $0.23, beats on revenue [7/29/2021 4:21 PM] |
97.04 |
1.28 (1.33%) |
92.50 |
-3.26 (-3.40%) |
63.45 - 104.74 |
363,251 |
250,000 |
792 |
|
|
04-05-2021 |
AH |
4:15 PM ET (May 4) |
DLB |
Dolby Laboratories |
10,370 |
0.73 |
0.47 |
0.86 |
Dolby Laboratories EPS beats by $0.24, beats on revenue [5/4/2021 4:18 PM] |
96.94 |
-6.59 (-6.37%) |
103.53 |
0.0 (0.00%) |
52.13 - 104.74 |
1,644,394 |
570,000 |
1,623 |
|
|
28-01-2021 |
AH |
4:15 PM ET (Jan 28) |
DLB |
Dolby Laboratories |
9,410 |
1.28 |
0.86 |
0.47 |
Dolby Laboratories EPS beats by $0.44, beats on revenue [1/28/2021 4:22 PM] |
88.11 |
-1.09 (-1.22%) |
92.50 |
3.30 (3.70%) |
44.68 - 97.78 |
673,973 |
475,284 |
1,353 |
|
|
12-11-2020 |
AH |
4:15 PM ET (Nov 12) |
DLB |
Dolby Laboratories |
8,460 |
0.28 |
0.20 |
0.43 |
Dolby Laboratories EPS beats by $0.11, beats on revenue [11/12/2020 4:38 PM] |
87.09 |
5.35 (6.55%) |
87.00 |
5.26 (6.44%) |
44.68 - 87.63 |
816,351 |
771,169 |
11,827 |
|
|
03-08-2020 |
AH |
4:15 PM ET (Aug 3) |
DLB |
Dolby Laboratories |
6,950 |
0.70 |
0.13 |
0.38 |
Dolby Laboratories EPS beats by $0.59, beats on revenue [8/3/2020 4:17 PM] |
70.96 |
1.00 (1.43%) |
70.00 |
0.04 (0.06%) |
44.68 - 73.94 |
265,141 |
296,619 |
913 |
|
|